2,207
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Comparing hydrazine-derived reactive groups as inhibitors of quinone-dependent amine oxidases

, , , , &
Pages 496-503 | Received 11 Aug 2016, Accepted 22 Nov 2016, Published online: 23 Jan 2017

References

  • López B, González A, Hermida N, et al. Role of lysyl oxidase in myocardial fibrosis: From basic science to clinical aspects. Am J Physiol Heart Circ Physiol 2010;299:H1–9.
  • Murawaki Y, Kusakabe Y, Hirayama C. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin. Hepatology 1991;14:1167–73.
  • Siegel RC, Chen KH, Greenspan JS, Aguiar JM. Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat. Proc Natl Acad Sci USA 1978;75:2945–9.
  • Wilgus M–L, Borczuk AC, Stoopler M, et al. Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival. Cancer 2011;117:2186–91.
  • Albinger–Hegyi A, Stoeckli SJ, Schmid S, et al. Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph nodemetastasis in oral and oropharyngeal squamous cell carcinoma (OSCC). Int J Cancer 2010;126:2653–62.
  • Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 2001;70:1–32.
  • Barker HE, Cox TR, Erler JT. The rationale for targeting the LOX family in cancer. Nat Rev Cancer 2012;12:540–52.
  • El-Haibi CP, Bell GW, Zheng J, et al. Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc Nat Acad Sci USA 2012;109:17460–5.
  • Cox TR, Bird D, Baker A–M, et al. LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res 2013;73:1721–32.
  • Baker AM, Bird D, Welti JC, et al. Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis. Cancer Res 2012;73:583–94.
  • Payne SL, Fogelgren B, Hess AR, et al. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res 2005;65:11429–36.
  • Kaneda A, Wakazono K, Tsukamoto T, et al. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res 2004;64:6410–15.
  • Wei L, Song XR, Sun J–J, et al. Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration. Cancer Biother Radiopharm 2012;27:672–7.
  • Yang X, Li S, Li W, et al. Inactivation of lysyl oxidase by β-aminopropionitrile inhibits hypoxia-induced invasion and migration of cervical cancer cells. Oncol Rep 2013;29:541–8.
  • Bondareva A, Downey CM, Ayres F, et al. The lysyl oxidase inhibitor, β-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells. PLoS One 2009;4:e5620.
  • Lopez KM, Greenaway FT. Identification of the copper-binding ligands of lysyl oxidase. J Neural Transm (Vienna) 2011;118:1101–9.
  • Chen X, Greenaway FT. Identification of the disulfide bonds of lysyl oxidase. J Neural Transm (Vienna) 2011;118:1111–14.
  • (a) Wilmot CM, Murray JM, Alton G, et al. Catalytic mechanism of the quinoenzyme amine oidase from Escherichia coli: Exploring the reductive half-reaction. Biochemistry 1997;36:1608–20. (b) Jakobsson E, Nilsson J, Ogg D, Kleywegt GJ. Structure of human semicarbazide-sensitive amine oxidase/vascualr adhesion protein-1. Acta Cryst D Biol Crystallogr 2005;61:1550–62. (c) Langley DB, Trambaiolo DM, Duff AP, et al. Complexes of the copper-containing amine oxidase from Arthobacter globiformis with the inhibitors benzylhydrazine and tranylcypromine. Acta Cryst F Struct Biol Cryst Commun 2008;64:577–83. (d) Murakawa T, Hayashi H, Taki M, et al. Structural insights into the substrate specificity of bacterial copper amine oxidase obtained by using irreversible inhibitors. J Biochem 2012;151:167–78.
  • (a) Duff AP, Cohen AE, Ellis PJ, et al. The crystal structure of Pichia pastoris lysyl oxidase. Biochemistry 2003;42:15148–57. (b) Duff AP, Cohen AE, Ellis PJ, et al. The 1.23 A structure of Pichia pastoris lysyl oxidase reveals a lysine–lysine cross-link. Acta Cryst D Biol Crystallogr 2006;62:1073–84.
  • Numata Y, Takei T, Hayakawa T. Hydralazine as an inhibitor of lysyl oxidase activity. Biochem Pharmacol 1981;30:3125–6.
  • Rinaldi A, Floris G, Sabatini S, et al. Reaction of beef plasma and lentil seedlings Cu-amine oxidases with phenylhydrazine. Biochem Biophys Res Commun 1983;115:841–8.
  • Falk MC. Stoichiometry of phenylhydrazine inactivation of pig plasma amine oxidase. Biochemistry 1983;22:3740–5.
  • Morpurgo L, Agostinelli E, Mondovi B, et al. Bovine serum amine oxidase: half-site reactivity with phenylhydrazine, semicarbazide, and aromatic hydrazides. Biochemistry 1992;31:2615–21.
  • Wang SX, Mure M, Medzihradszky KF, et al. A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. Science 1996;273:1078–84.
  • Williamson PR, Kittler JM, Thanassi JW, Kagan HM. Reactivity of a functional carbonyl moiety in bovine aortic lysyl oxidase. Evidence against pyridoxal 5'-phosphate. Biochem J 1986;235:597–605.
  • Mure M, Wang SX, Klinman JP. Synthesis and characterization of model compounds of the lysine tyrosyl quinone cofactor of lysyl oxidase. J Am Chem Soc 2003;125:6113–25.
  • Tang SS, Trackman PC, Kagan HM. Reaction of aortic lysyl oxidase with beta-aminopropionitrile. J Biol Chem 1983;258:4331–8.
  • Trackman PC, Kagan HM. Nonpeptidyl amine inhibitors are substrates of lysyl oxidase. J Biol Chem 1979;254:7831–6.
  • Papadantonakis N, Matsuura S, Ravid K. Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection. Blood 2012;120:1774–81.
  • Floris G, Giartosi A, Rinaldi A. Diamine oxidase from Lens Esculenta seedlings: purification and properties. Phytochemistry 1983;22:1871–4.
  • Padiglia A, Medda R, Floris G. Lentil seedling amine oxidase: interaction with carbonyl reagents. Biochem Int 1992;28:1097–107.
  • (a). Williams MA, Kagan HM. Assessment of lysyl oxidase variants by urea gel electrophoresis: evidence against disulfide isomers as bases of the enzyme heterogeneity. Anal Biochem 1985;149:430–7. (b) Kagan HM, Sullivan KA, Olsson TA III, Cronlund AL. Purification and properties of four species of lysyl oxidase from bovine aorta. Biochem J 1979;177:203–14.
  • Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76–85.
  • (a). Cronshaw AD, MacBeath JR, Shackleton DR, et al. TRAMP (tyrosine rich acidic matrix protein), a protein that co-purifies with lysyl oxidase from porcine skin. Identification of TRAMP as the dermatan sulphate proteoglycan-associated 22K extracellular matrix protein. Matrix 1993;13:255–66. (b) Domenicucci C, Goldberg HA, Sodek J. Identification of lysyl oxidase and TRAMP as the major proteins in dissociative extracts of the demineralized collagen matrix of porcine dentine. Connect Tissue Res 1997;36:151–63.
  • Palamakumbura AH, Trackman PC. A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal Biochem 2002;300:245–51.
  • Kitz R, Wilson IB. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J Biol Chem 1962;237:3245–9.
  • Kumar V, Dooley DM, Freeman HC, et al. Crystal structure of a eukaryotic (pea seedling) copper-containing amine oxidase at 2.2 A resolution. Structure 1996;4:943–55.
  • Parsons ZD, Gates KS, Redox regulation of protein tyrosine phosphatases: Methods for kinetic analysis of covalent enzyme inactivation. In: Cadenas E, Packer L, eds. Methods in enzymology. Burlington: Academic Press; 2013:129–154.
  • Fornieri C, Baccarani–Contri M, Quaglino D Jr, Pasquali–Ronchetti I. Lysyl oxidase activity and elastin/glycosaminoglycan interactions in growing chick and rat aortas. J Cell Biol 1987;105:1463–9.
  • Mercier N, Kakou A, Challande P, et al. Comparison of the effects of semicarbazide and beta-aminopropionitrile on the arterial extracellular matrix in the Brown Norway rat. Toxicol Appl Pharmacol 2009;239:258–67.
  • Tang SS, Chichester CO, Kagan HM. Comparative sensitivities of purified preparations of lysyl oxidase and other amine oxidases to active site-directed enzyme inhibitors. Connect Tissue Res 1989;19:93–103.
  • Schwartz PA, Kuzmic P, Solowiej J, et al. Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanism of drug resistance. Proc Nat Acad Sci USA 2014;111:173–8.
  • Nurminen E, Pihlavisto M, Lazar L, et al. Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors. J Med Chem 2011;54:2143–54.